ENGN NASDAQ Week ended 31 Jul 2026

Weekly Investor Report

enGene Holdings Inc. Common Stock · Healthcare · Biotechnology

Open interactive chart View report data
Latest close 1.79 USD
-1.6% latest week
Weekly setup

Mixed setup

The weekly trend is not active. Price is -68.2% below the Trend Line and sits at 3.6% of its 52-week range. The latest completed week returned -1.6%, after a 0.6% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. Options positioning is volatility with 56/100 conviction, while the latest news-sentiment score is 47/100. Near-term considerations: volume confirmation is below normal; earnings are due in 39d.

Setup score 28 out of 100
Latest Close 1.79 USD 31 Jul 2026
1W Return -1.6% latest completed week
4W Return 0.6% short-term follow-through
12W Return 19.3% quarterly tape
Trend Breadth 48.1% 25 of 52 weeks active
Volume Ratio 0.3x vs 13-week average
What is working
  • No strong opportunity cluster is confirmed yet; monitor trend and activity pressure.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Activity pressure is negative, which weakens the current setup.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -1.6% Latest completed week; four-week move 0.6%. Indicator stack 26/39 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Options pressure Volatility 56/100 conviction; expected move 12.5%. News sentiment 47/100 63 relevant articles in the latest sentiment read. Event risk 39d Next report is scheduled for 10 Sep 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is -68.2% below the Trend Line and sits at 3.6% of its 52-week range. The latest completed week returned -1.6%, after a 0.6% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.3x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.0612-week average 0.09

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure0/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.06Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 0.6% over four weeks, 19.3% over 12 weeks, and -53.3% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W-1.6%
4W0.6%
12W19.3%
26W-81.2%
52W-53.3%
Active trend streak0 weeks
Active weeks in one year25
Trend breadth48.1%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure-0.79Latest activity-pressure read.
Pressure change37.9%Four-week change in activity pressure.
Leadership-74.32Latest relative-leadership reading.
RS change2.3%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 30 Apr 2026 Field coverage 61% Model confidence 61%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength27/100Blend of value, momentum, and quality. Underlying universe rank 74; rank 1 is best.
Value40/100Relative valuation strength. Underlying universe rank 61; rank 1 is best.
Quality38/100Profitability and accounting quality. Underlying universe rank 63; rank 1 is best.
Momentum40/100Medium-term price momentum. Underlying universe rank 61; rank 1 is best.
Growth40/100Revenue and earnings growth. Underlying universe rank 61; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
-
Price divided by trailing earnings.
Price / sales
-
Market value relative to trailing revenue.
EV / EBITDA
-
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
-86.6%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
-
Gross profit retained from each unit of revenue.
Operating margin
-
Operating profit retained from revenue.
Free-cash-flow margin
-
Free cash flow generated from revenue.
Return on invested capital
-36.7%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
-
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-
Latest one-year free-cash-flow growth.
Piotroski F-score
2/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
-
Net share repurchases relative to market value.
Shareholder yield
-
Dividend yield plus net buyback yield.
Net debt / EBITDA
-0.0x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningVolatility

ENGN shows volatility options pressure with a 56/100 conviction score, put-call volume ratio of 0.00, expected move of 12.5%, and Sharemaestro trend signal inactive.

Conviction56/100
Expected move12.5%
Put/call volume0.00
Pressure95
Speculation40
Volatility76
Trend agreement0
Open options detail
Insider activity-

No recent insider transactions are stored for this company.

News sentiment47/100

Weighted news tone is neutral across 63 relevant articles.

8 positive · 42 neutral · 13 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings39dNext report is scheduled for 10 Sep 2026; event risk rises as the date approaches.
Options expected move12.5%Nearest-chain priced movement where available.
52-week drawdown-85.4%Distance below the 52-week high.
13-week volatility22.6%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher13 of 2612 weeks finished lower.
Best week+14.7%Week of 15 May.
Worst week-79.3%Week of 8 May.
Latest week-1.6%Week of 31 Jul.

Shape of recent returns

Strong gains8
Modest gains5
Flat weeks1
Modest losses4
Sharp losses8
Recent vol22.6%13-week weekly-return volatility.
Base vol16.4%52-week weekly-return volatility.
Up/down split28/21Count of positive and negative weeks in the 52-week window.
Average skew10.5% / -12.1%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape23/100

Trend, activity pressure, participation, and risk combine to a 23/100 tape read.

 Indicator analysis9/100

Latest 12-week confirmation: trend 0/12, activity pressure 0/12, relative leadership 0/12.

Activity pressure 0.06; No reversal markers Factors35/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 50; Small Cap Core rank 61 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Options37/100

ENGN shows volatility options pressure with a 56/100 conviction score, put-call volume ratio of 0.00, expected move of 12.5%, and Sharemaestro trend signal inactive.

Volatility · Volatility expansion watch · Expected move 12.5% Sentiment47/100

Weighted news tone is neutral across 63 relevant articles.

GE HealthCare’s (NASDAQ:GEHC) Q2 CY2026: Beats On Revenue, Stock Soars Insiders50/100

No recent insider transaction evidence is stored.

 Earnings39d

Next report is scheduled for 10 Sep 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 20261.79 USD-1.6%5.63 USD7.41 USD-0.79-74.322.8MOff
24 Jul 20261.82 USD0.0%5.86 USD7.45 USD-0.91-73.963.9MOff
17 Jul 20261.82 USD-4.2%6.12 USD7.49 USD-0.99-74.564.8MOff
10 Jul 20261.90 USD6.7%6.35 USD7.53 USD-1.10-74.758.3MOff
3 Jul 20261.78 USD1.7%6.57 USD7.57 USD-1.28-76.063.3MOff
26 Jun 20261.75 USD1.7%6.78 USD7.61 USD-1.41-76.455.8MOff
19 Jun 20261.72 USD6.2%6.99 USD7.65 USD-1.51-78.075.6MOff
12 Jun 20261.62 USD-1.2%7.16 USD7.70 USD-1.57-78.933.0MOff
5 Jun 20261.64 USD-11.4%7.39 USD7.74 USD-1.50-78.344.3MOff
29 May 20261.85 USD12.8%7.54 USD7.79 USD-1.38-76.875.0MOff
22 May 20261.64 USD-4.7%7.72 USD7.83 USD-1.23-79.088.3MOff
15 May 20261.72 USD14.7%7.94 USD7.88 USD-1.05-78.0322.0MOff
8 May 20261.50 USD-79.3%8.19 USD7.92 USD-0.92-81.0442.1MOff
1 May 20267.25 USD-9.3%8.42 USD7.97 USD-0.92-3.983.4MOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.